Trademark Details For GINGAFILL (Serial Number 74510570)

  •  Home
  •  Print
GINGAFILL
  • Rank
    Global Trademark Influence Ranking
    3398
0
0
0
0
Serial Number  United States - USPTO 74510570
Registration Number 1890784
Mark
GINGAFILL
Filing Date Apr-08-1994
Status
Registered  
REGISTERED A.. (800)
REGISTERED AND RENEWED
Attorney Name
TTAB
0



  • Mark Literal Elements:

005Pharmaceuticals

U.S Class(es): 018

Class Status: Active

First Use: Dec-13-1993

First Use in Commerce: Dec-13-1993





Correspondences

NameCharles A. LaffMichael Best Friedrich LLP
Address444 West Lake Street, Suite 3200 CHICAGO,IL 60606 UNITED STATES

Prosecution History

DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Aug-24-1994ASSIGNED TO EXAMINER   DOCKD
Jan-02-1995NOTICE OF PUBLICATION   NPUBO
Jan-31-1995PUBLISHED FOR OPPOSITION   PUBOA
Apr-25-1995REGISTERED-PRINCIPAL REGISTER   R.PRA
Apr-20-2005TEAS SECTION 8 9 RECEIVED   E89RI
Aug-18-2005ASSIGNED TO PARALEGAL   PLGLA
Aug-26-2005REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED   89AGO
Sep-06-1994APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAO
Apr-16-2001REGISTERED - SEC. 8 (6-YR) SEC. 15 FILED   815FI
Jun-30-2001REGISTERED - SEC. 8 (6-YR) ACCEPTED SEC. 15 ACK.   C15AO
Apr-20-2005REGISTERED - COMBINED SECTION 8 (10-YR) SEC. 9 FILED   89AFI
Aug-26-2005REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)   RNL1Q
Jun-28-2007CASE FILE IN TICRS   CFITO
May-08-2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL   APREA
May-08-2015NOTICE OF ACCEPTANCE OF SEC. 8 9 - E-MAILED   NA89E
Apr-25-2017TEAS CHANGE OF CORRESPONDENCE RECEIVED   TCCAI
Feb-19-2006TEAS CHANGE OF CORRESPONDENCE RECEIVED   TCCAI
Oct-08-2007TEAS CHANGE OF CORRESPONDENCE RECEIVED   TCCAI
Apr-23-2015TEAS SECTION 8 9 RECEIVED   E89RI
May-08-2015REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED   89AGO
May-08-2015REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)   RNL2Q
Apr-25-2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED   REM2E